KKR highlights fee growth, ABF expansion and maintained 2026 guidance

Transcript intelligence

What changed

Relative to the prior-quarter analysis, the current analysis adds the HealthCare Royalty Partners acquisition, a $50 billion Energy Capital Partners joint venture, record unrealized carried interest, and ABF AUM of $75 billion. It also continues the prior emphasis on fundraising, fee growth, insurance expansion, and portfolio monetization.

Guidance delta

Maintained; the analysis says 2026 guidance remains on track.

Key takeaways

• The analysis describes record-high fee-related earnings and a 69% FRE margin, with management fees up 18% year over year.
• Asset-Based Finance AUM reached $75 billion and was identified as a core growth engine.
• The analysis cites $37 billion of year-to-date deployment and $115 billion of uncalled capital as support for future earnings.
• KKR added HealthCare Royalty Partners and formed a $50 billion joint venture with Energy Capital Partners.
• Management maintained 2026 guidance, while the analysis points to fee expansion, portfolio monetization and third-party capital as growth drivers.

Management priorities

• Expand K-Series credit products and convert KCOP to K-ABF.
• Raise capital for the Asian infrastructure strategy and broaden real-asset offerings.
• Launch a public private-equity product tied to K-Series vehicles.
• Integrate HealthCare Royalty Partners into the broader credit platform.
• Build the Energy Capital Partners joint-venture pipeline.